Pfizer, GSK Price-Fixing Suit Won't Get High Court Review

Law360, New York (June 3, 2013, 1:26 PM EDT) -- The U.S. Supreme Court declined Monday to review a lower court's dismissal of a consolidated antitrust case alleging that Pfizer Inc., GlaxoSmithKline PLC and other drug companies conspired to inflate U.S. drug prices.

The high court denied a petition filed by a group of retail pharmacies claiming their antitrust suit against more than a dozen major drug companies and industry group Pharmaceutical Research & Manufacturers of America was improperly dismissed by a California state judge.

The case alleged that the drug companies and PhRMA conspired to...
To view the full article, register now.